Ann: PharmAust to present at NWR Virtual Healthcare Conference, page-86

Their watching Lastly, but to be honest they are always watching, they have teams dedicated to that purpose and as you correctly point out they are not fools and know when the right time and place is. 3 Important things.

1. Does the product work...... We are in as good a position as is possible after a Phase 1 trial. [Unbelievably good position]
2. Is there a need for the product......... Well, that an easy question to answer. Absolutely.
3. Is the management working hard..... In my mind, I have no doubt the CEO and his team are giving it everything the have, and the BOD is backing them.

It's always good to have someone playing the role of Devils Advocate, but I think Mr Buckland just likes to get a response. It is difficult to imagine how PAA could be in a better position after a Phase 1 trial.

One trial away from applying for registration with an ODD [TBC] in our back pocket.

News on the investors page this morning. The CEO will soon be in the USA hitting the pavement meeting with the people who matter, along with attending conferences etc, this is the sort of unseen and unreported effort that creates opportunities. Hitting endpoints is where it starts but there is a lot of hard work needed after that.

Cheers everyone.